Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview of the field.

Jorge Alberto Costa e Silva1

  • 1The International Center for Mental Health Policy and Research, New York University-School of Medicine, New York, NY, USA. jacs@vetor.com.br

Metabolism: Clinical and Experimental
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urban environment and psychiatric disorders: a review of the neuroscience and biology.

Metabolism: clinical and experimental·2019
Same author

The future of psychiatry: brain devices.

Metabolism: clinical and experimental·2017
Same author

Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol.

CNS spectrums·2009
Same author

Autism, a brain developmental disorder: some new pathopysiologic and genetics findings.

Metabolism: clinical and experimental·2008
Same author

Sleep disorders in psychiatry.

Metabolism: clinical and experimental·2006
Same author

[Brain aging, biological and psychosocial aspect].

Bulletin de l'Academie nationale de medecine·2006

Depression is a common, serious mood disorder impacting millions. Current treatments are insufficient, highlighting the urgent need for novel antidepressant therapies.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Depression has a long history, but scientific understanding is recent.
  • Affects ~5% of the population, with chronic forms common in patients with other diseases.
  • Neuroimaging reveals abnormalities in brain regions like the prefrontal cortex and amygdala.

Purpose of the Study:

  • To provide an overview of current knowledge on depression.
  • To highlight the neurobiological, genetic, hormonal, and immune factors involved.
  • To underscore the need for new antidepressant treatments due to limited drug efficacy.

Main Methods:

  • Historical overview of depression research.
  • Review of neuroimaging studies on mood disorders.
  • Examination of genetic, hormonal, and immune system influences.

Related Experiment Videos

  • Analysis of antidepressant treatment response rates.

    • Main Results:

    • Depression is prevalent, persistent, and costly.
    • Neuroimaging identifies specific brain abnormalities.
    • Stress, genetics, hormones, and immune factors play roles.
    • Only one-third of patients respond to current antidepressants.

    Conclusions:

    • Depression is a complex disorder with multiple contributing factors.
    • Current pharmacotherapy is inadequate for many patients.
    • Novel antidepressant development is critically needed.